Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 18/20 | 0.64 |
| ▸ | CSNK2A2 | P19784 | 16/20 | 0.61 |
| ▸ | CSNK2B | P67870 | 13/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.54 |
| ▸ | CSNK2A3 | Q8NEV1 | 4/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | LATS1 | O95835 | 1/20 | 0.49 |
| ▸ | LATS2 | Q9NRM7 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26048821 | 0.90 | CSNK2A1 (0.63) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL27320316 | 0.89 | CSNK2A1 (0.76) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL25249993 | 0.88 | CSNK2A1 (0.68) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL27319864 | 0.88 | CSNK2A1 (0.66) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL30487015 | 0.88 | CSNK2A1 (0.68) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL27320323 | 0.88 | CSNK2A2 (0.62) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL10131779 | 0.88 | CSNK2A1 (0.77) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL27322354 | 0.87 | CSNK2A1 (0.67) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL27321691 | 0.86 | CSNK2A1 (0.58) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL10131527 | 0.85 | CSNK2A1 (0.83) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024052692-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |